CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | McAnear Justin J. Chief Financial Officer | Sale | −400 | $152.08 | $61K | 21,174 |
| 2021-03-08 | McAnear Justin J. Chief Financial Officer | Sale | −300 | $154.14 | $46K | 20,874 |
| 2021-03-08 | McAnear Justin J. Chief Financial Officer | Sale | −100 | $154.82 | $15K | 20,774 |
| 2021-03-08 | McAnear Justin J. Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 450,159 | ||
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −900 | $178.80 | $161K | 457,591 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −1,317 | $179.75 | $237K | 456,274 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −500 | $180.95 | $90K | 455,774 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −700 | $182.02 | $127K | 455,074 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −600 | $183.94 | $110K | 454,474 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −400 | $184.93 | $74K | 454,074 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −2,883 | $186.14 | $537K | 451,191 |
| 2021-03-01 | STUELPNAGEL JOHN R Director | Sale | −200 | $186.85 | $37K | 450,991 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −400 | $189.51 | $76K | 465,591 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −1,400 | $190.42 | $267K | 464,191 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −2,683 | $191.63 | $514K | 461,508 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −451 | $192.61 | $87K | 461,057 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −600 | $194.60 | $117K | 460,457 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −800 | $195.43 | $156K | 459,657 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −633 | $197.36 | $125K | 459,024 |
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −233 | $198.08 | $46K | 458,791 |
Page 46 of 57 · 1,128 trades